Literature DB >> 3065099

Maximal effective dose of cerulein in the secretin-cerulein test.

L Gullo1.   

Abstract

In order to determine whether the doses of cerulein generally used in the secretin-cerulein test are supramaximal, the pancreatic secretion of enzymes and bicarbonate in response to intravenous infusion of cerulein plus secretin was studied in 6 subjects on two separate days at the respective doses of 50 ng/kg/h and 0.5 CU/kg/h on one day, and 100 ng/kg/h and 1 CU/kg/h on the other. In all subjects studied, the infusion of cerulein at the dose of 100 ng/kg/h caused a pancreatic enzyme response significantly higher than that produced by 50 ng/kg/h, demonstrating that the doses of cerulein generally used in clinical practice to explore the exocrine pancreatic function are not supramaximal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3065099     DOI: 10.1159/000199630

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  1 in total

Review 1.  Rediscovery of Ceruletide, a CCK Agonist, as an Analgesic Drug.

Authors:  Jan M Keppel Hesselink
Journal:  J Pain Res       Date:  2020-01-15       Impact factor: 3.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.